$ICN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VALEANT PHARMACEUTICALS INTERNATIONAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VALEANT PHARMACEUTICALS INTERNATIONAL. Get notifications about new insider transactions in VALEANT PHARMACEUTICALS INTERNATIONAL for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Grant | A | 19.66 | 40 | 786 | 180 | 140 to 180 (+28.57 %) |
Sep 01 2006 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Grant | A | 19.66 | 40 | 786 | 180 | 140 to 180 (+28.57 %) |
Aug 29 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 19.17 | 117 | 2,243 | 26,337 | 26.2 K to 26.3 K (+0.45 %) |
Aug 29 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.17 | 156 | 2,991 | 34,613 | 34.5 K to 34.6 K (+0.45 %) |
Aug 04 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Option Exercise | M | 10.05 | 39,800 | 399,990 | 0 | |
Aug 04 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Buy | M | 10.05 | 39,800 | 399,990 | 59,246 | 19.4 K to 59.2 K (+204.67 %) |
Aug 07 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 17.99 | 80,500 | 1,448,195 | 10,871,200 | 10.8 M to 10.9 M (+0.75 %) |
Aug 07 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 18.00 | 360,200 | 6,483,600 | 10,790,700 | 10.4 M to 10.8 M (+3.45 %) |
Aug 01 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.26 | 348 | 6,006 | 26,220 | 25.9 K to 26.2 K (+1.35 %) |
Aug 01 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.26 | 87 | 1,502 | 22,615 | 22.5 K to 22.6 K (+0.39 %) |
Aug 01 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.26 | 348 | 6,006 | 34,457 | 34.1 K to 34.5 K (+1.02 %) |
Jul 28 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 17.00 | 100 | 1,700 | 10,430,500 | 10.4 M to 10.4 M (0.00 %) |
Jul 28 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 16.98 | 100,000 | 1,698,000 | 10,430,400 | 10.3 M to 10.4 M (+0.97 %) |
Jul 28 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 16.95 | 32,200 | 545,790 | 10,330,400 | 10.3 M to 10.3 M (+0.31 %) |
Jul 25 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 16.87 | 120,400 | 2,031,148 | 10,298,200 | 10.2 M to 10.3 M (+1.18 %) |
Jul 25 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 15.91 | 100,000 | 1,591,000 | 10,177,800 | 10.1 M to 10.2 M (+0.99 %) |
Jul 18 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 15.89 | 150,300 | 2,388,267 | 10,077,800 | 9.9 M to 10.1 M (+1.51 %) |
Jul 18 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 15.82 | 200,000 | 3,164,000 | 9,927,500 | 9.7 M to 9.9 M (+2.06 %) |
Jul 18 2006 | ICN | VALEANT PHARMACEUT ... | VA PARTNERS LLC | 10% Owner | Buy | P | 15.86 | 262,400 | 4,161,664 | 9,727,500 | 9.5 M to 9.7 M (+2.77 %) |
Jul 06 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.10 | 594 | 10,157 | 25,872 | 25.3 K to 25.9 K (+2.35 %) |
Jul 06 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.10 | 548 | 9,371 | 22,528 | 22 K to 22.5 K (+2.49 %) |
Jul 06 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.10 | 439 | 7,507 | 34,109 | 33.7 K to 34.1 K (+1.30 %) |
Jun 29 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.42 | 43 | 749 | 25,278 | 25.2 K to 25.3 K (+0.17 %) |
Jun 29 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.42 | 86 | 1,498 | 21,980 | 21.9 K to 22 K (+0.39 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Grant | A | 17.61 | 44 | 775 | 140 | 96 to 140 (+45.83 %) |
Jun 29 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.42 | 43 | 749 | 33,670 | 33.6 K to 33.7 K (+0.13 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | Cooper John | EVP, Global Manufac ... | Grant | A | 17.61 | 44 | 775 | 140 | 96 to 140 (+45.83 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Grant | A | 17.61 | 44 | 775 | 140 | 96 to 140 (+45.83 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.61 | 112 | 1,972 | 438 | 326 to 438 (+34.36 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Grant | A | 17.61 | 133 | 2,342 | 421 | 288 to 421 (+46.18 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Grant | A | 17.61 | 44 | 775 | 140 | 96 to 140 (+45.83 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 17.61 | 95 | 1,673 | 959 | 864 to 959 (+11.00 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.61 | 96 | 1,691 | 128 | 32 to 128 (+300.00 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 17.61 | 126 | 2,219 | 754 | 628 to 754 (+20.06 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 17.61 | 126 | 2,219 | 754 | 628 to 754 (+20.06 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 17.61 | 126 | 2,219 | 754 | 628 to 754 (+20.06 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 17.61 | 88 | 1,550 | 352 | 264 to 352 (+33.33 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.61 | 151 | 2,659 | 839 | 688 to 839 (+21.95 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Grant | A | 17.61 | 44 | 775 | 140 | 96 to 140 (+45.83 %) |
Jun 05 2006 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Grant | A | 17.61 | 44 | 775 | 140 | 96 to 140 (+45.83 %) |
May 31 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 16.81 | 90 | 1,513 | 25,235 | 25.1 K to 25.2 K (+0.36 %) |
May 31 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 16.81 | 491 | 8,254 | 21,894 | 21.4 K to 21.9 K (+2.29 %) |
May 26 2006 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Buy | P | 16.56 | 1,500 | 24,840 | 3,500 | 2 K to 3.5 K (+75.00 %) |
May 31 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 16.81 | 491 | 8,254 | 33,627 | 33.1 K to 33.6 K (+1.48 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 16.72 | 7,177 | 119,999 | 25,145 | 18 K to 25.1 K (+39.94 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 16.72 | 14,354 | 239,999 | 21,403 | 7 K to 21.4 K (+203.63 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 16.72 | 7,177 | 119,999 | 27,981 | 20.8 K to 28 K (+34.50 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 16.72 | 7,177 | 119,999 | 27,981 | 20.8 K to 28 K (+34.50 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 16.72 | 7,177 | 119,999 | 27,981 | 20.8 K to 28 K (+34.50 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 16.72 | 7,177 | 119,999 | 33,136 | 26 K to 33.1 K (+27.65 %) |
May 25 2006 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 16.72 | 7,177 | 119,999 | 19,689 | 12.5 K to 19.7 K (+57.36 %) |
May 01 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.90 | 210 | 3,759 | 17,968 | 17.8 K to 18 K (+1.18 %) |
May 01 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.90 | 210 | 3,759 | 7,049 | 6.8 K to 7 K (+3.07 %) |
May 01 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.90 | 210 | 3,759 | 25,959 | 25.7 K to 26 K (+0.82 %) |
Apr 04 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 16.06 | 272 | 4,368 | 6,839 | 6.6 K to 6.8 K (+4.14 %) |
Apr 04 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 16.06 | 467 | 7,500 | 17,758 | 17.3 K to 17.8 K (+2.70 %) |
Apr 04 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 16.06 | 467 | 7,500 | 25,749 | 25.3 K to 25.7 K (+1.85 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Grant | A | 15.86 | 49 | 777 | 96 | 47 to 96 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Grant | A | 15.86 | 147 | 2,331 | 288 | 141 to 288 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Grant | A | 15.86 | 49 | 777 | 96 | 47 to 96 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | Cooper John | EVP, Global Manufac ... | Grant | A | 15.86 | 49 | 777 | 96 | 47 to 96 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Grant | A | 15.86 | 49 | 777 | 96 | 47 to 96 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Grant | A | 15.86 | 49 | 777 | 96 | 47 to 96 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Grant | A | 15.86 | 49 | 777 | 96 | 47 to 96 (+104.26 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 15.86 | 86 | 1,364 | 326 | 240 to 326 (+35.83 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 15.86 | 142 | 2,252 | 864 | 722 to 864 (+19.67 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 15.86 | 32 | 508 | 32 | 0 to 32 |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 15.86 | 104 | 1,649 | 628 | 524 to 628 (+19.85 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 15.86 | 104 | 1,649 | 628 | 524 to 628 (+19.85 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 15.86 | 104 | 1,649 | 628 | 524 to 628 (+19.85 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 15.86 | 61 | 967 | 264 | 203 to 264 (+30.05 %) |
Apr 03 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 15.86 | 126 | 1,998 | 688 | 562 to 688 (+22.42 %) |
Mar 28 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 16.03 | 94 | 1,507 | 17,291 | 17.2 K to 17.3 K (+0.55 %) |
Mar 28 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 16.03 | 188 | 3,014 | 6,567 | 6.4 K to 6.6 K (+2.95 %) |
Mar 28 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 16.03 | 141 | 2,260 | 25,282 | 25.1 K to 25.3 K (+0.56 %) |
Mar 01 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.82 | 336 | 5,988 | 17,197 | 16.9 K to 17.2 K (+1.99 %) |
Mar 01 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.82 | 336 | 5,988 | 6,379 | 6 K to 6.4 K (+5.56 %) |
Mar 01 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.82 | 168 | 2,994 | 25,141 | 25 K to 25.1 K (+0.67 %) |
Jan 31 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Director | Grant | A | 17.86 | 252 | 4,501 | 6,043 | 5.8 K to 6 K (+4.35 %) |
Jan 31 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.86 | 252 | 4,501 | 16,861 | 16.6 K to 16.9 K (+1.52 %) |
Jan 31 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.86 | 252 | 4,501 | 24,973 | 24.7 K to 25 K (+1.02 %) |
Jan 04 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Chairman of the Boa ... | Grant | A | 18.17 | 791 | 14,372 | 5,791 | 5 K to 5.8 K (+15.82 %) |
Jan 04 2006 | ICN | VALEANT PHARMACEUT ... | O LEARY ROBERT | Chairman of the Boa ... | Grant | A | 18.08 | 5,000 | 90,400 | 5,000 | 0 to 5 K |
Jan 04 2006 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 18.17 | 413 | 7,504 | 16,609 | 16.2 K to 16.6 K (+2.55 %) |
Jan 04 2006 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 18.17 | 413 | 7,504 | 24,721 | 24.3 K to 24.7 K (+1.70 %) |
Dec 28 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 18.38 | 41 | 754 | 16,196 | 16.2 K to 16.2 K (+0.25 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | Cooper John | EVP, Global Manufac ... | Grant | A | 16.46 | 47 | 774 | 47 | 0 to 47 |
Dec 28 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 18.38 | 41 | 754 | 24,308 | 24.3 K to 24.3 K (+0.17 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Grant | A | 16.46 | 47 | 774 | 47 | 0 to 47 |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Grant | A | 16.46 | 47 | 774 | 47 | 0 to 47 |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Grant | A | 16.46 | 47 | 774 | 47 | 0 to 47 |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Grant | A | 16.46 | 47 | 774 | 47 | 0 to 47 |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Grant | A | 16.46 | 47 | 774 | 47 | 0 to 47 |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Grant | A | 16.46 | 141 | 2,321 | 141 | 0 to 141 |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 16.46 | 78 | 1,284 | 241 | 163 to 241 (+47.85 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 16.46 | 64 | 1,053 | 207 | 143 to 207 (+44.76 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 16.46 | 147 | 2,420 | 733 | 586 to 733 (+25.09 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 16.46 | 108 | 1,778 | 532 | 424 to 532 (+25.47 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 16.46 | 108 | 1,778 | 532 | 424 to 532 (+25.47 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 16.46 | 108 | 1,778 | 532 | 424 to 532 (+25.47 %) |
Dec 05 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 16.46 | 121 | 1,992 | 567 | 446 to 567 (+27.13 %) |
Nov 30 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 0.00 | 360 | 0 | 360 | 0 to 360 |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Cooper John | EVP, Global Manufac ... | Option Exercise | A | 17.72 | 74,357 | 1,317,606 | 74,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Cooper John | EVP, Global Manufac ... | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Cooper John | EVP, Global Manufac ... | Grant | A | 0.00 | 10,000 | 0 | 15,420 | 5.4 K to 15.4 K (+184.50 %) |
Nov 30 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 360 | 0 | 360 | 0 to 360 |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Option Exercise | A | 17.72 | 84,357 | 1,494,806 | 84,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Bramlage Charles | President, European ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Option Exercise | A | 17.72 | 84,357 | 1,494,806 | 84,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | LAMON KIM DAVID | Pres. & Chief Scien ... | Grant | A | 0.00 | 10,000 | 0 | 11,446 | 1.4 K to 11.4 K (+691.56 %) |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | A | 17.72 | 84,357 | 1,494,806 | 84,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Grant | A | 0.00 | 10,000 | 0 | 13,446 | 3.4 K to 13.4 K (+290.19 %) |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 17.72 | 114,357 | 2,026,406 | 114,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | BAILEY BARY | EVP & CFO | Grant | A | 0.00 | 10,000 | 0 | 26,446 | 16.4 K to 26.4 K (+60.81 %) |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Option Exercise | A | 17.72 | 74,357 | 1,317,606 | 74,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | PRUETTE EILEEN | EVP, General Counse ... | Grant | A | 0.00 | 10,000 | 0 | 11,446 | 1.4 K to 11.4 K (+691.56 %) |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Option Exercise | A | 17.72 | 354,357 | 6,279,206 | 354,357 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Option Exercise | A | 17.72 | 5,643 | 99,994 | 5,643 | |
Nov 03 2005 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Grant | A | 0.00 | 30,000 | 0 | 43,796 | 13.8 K to 43.8 K (+217.45 %) |
Oct 31 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.18 | 174 | 2,989 | 15,795 | 15.6 K to 15.8 K (+1.11 %) |
Oct 31 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.18 | 87 | 1,495 | 23,907 | 23.8 K to 23.9 K (+0.37 %) |
Oct 04 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 20.02 | 375 | 7,508 | 23,820 | 23.4 K to 23.8 K (+1.60 %) |
Oct 04 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 20.02 | 375 | 7,508 | 15,621 | 15.2 K to 15.6 K (+2.46 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 20.02 | 58 | 1,161 | 163 | 105 to 163 (+55.24 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 20.02 | 110 | 2,202 | 586 | 476 to 586 (+23.11 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 20.02 | 81 | 1,622 | 424 | 343 to 424 (+23.62 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 20.02 | 81 | 1,622 | 424 | 343 to 424 (+23.62 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | KOPPES RICHARD | Director | Grant | A | 20.02 | 81 | 1,622 | 424 | 343 to 424 (+23.62 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 20.02 | 91 | 1,822 | 446 | 355 to 446 (+25.63 %) |
Sep 06 2005 | ICN | VALEANT PHARMACEUT ... | BURKHARDT EDWARD A | Director | Grant | A | 20.02 | 48 | 961 | 143 | 95 to 143 (+50.53 %) |
Aug 30 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 19.34 | 390 | 7,543 | 15,246 | 14.9 K to 15.2 K (+2.63 %) |
Aug 30 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 19.34 | 156 | 3,017 | 23,445 | 23.3 K to 23.4 K (+0.67 %) |
Aug 25 2005 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Buy | P | 19.21 | 10,000 | 192,073 | 10,000 | 0 to 10 K |
Aug 16 2005 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Option Exercise | M | 10.80 | 2,000 | 21,600 | 35,036 | |
Aug 16 2005 | ICN | VALEANT PHARMACEUT ... | Wheeler Wesley | President, North Am ... | Buy | M | 10.80 | 2,000 | 21,600 | 3,446 | 1.4 K to 3.4 K (+138.31 %) |
Aug 10 2005 | ICN | VALEANT PHARMACEUT ... | TYSON TIMOTHY | CEO and President | Buy | P | 19.85 | 2,000 | 39,700 | 13,796 | 11.8 K to 13.8 K (+16.95 %) |
Jul 06 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.81 | 421 | 7,498 | 14,856 | 14.4 K to 14.9 K (+2.92 %) |
Jul 06 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.81 | 421 | 7,498 | 23,289 | 22.9 K to 23.3 K (+1.84 %) |
Jun 29 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 17.93 | 84 | 1,506 | 14,435 | 14.4 K to 14.4 K (+0.59 %) |
Jun 29 2005 | ICN | VALEANT PHARMACEUT ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 17.93 | 84 | 1,506 | 22,868 | 22.8 K to 22.9 K (+0.37 %) |
May 26 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 21.07 | 5,695 | 119,994 | 14,132 | 8.4 K to 14.1 K (+67.50 %) |
Jun 01 2005 | ICN | VALEANT PHARMACEUT ... | ULLIAN ELAINE | Director | Grant | A | 20.63 | 219 | 4,518 | 14,351 | 14.1 K to 14.4 K (+1.55 %) |
May 26 2005 | ICN | VALEANT PHARMACEUT ... | THURMAN RANDY | Director | Grant | A | 21.07 | 7,594 | 160,006 | 28,291 | 20.7 K to 28.3 K (+36.69 %) |
May 26 2005 | ICN | VALEANT PHARMACEUT ... | MELAS KYRIAZI THEO | Director | Grant | A | 21.07 | 5,695 | 119,994 | 20,804 | 15.1 K to 20.8 K (+37.69 %) |
May 26 2005 | ICN | VALEANT PHARMACEUT ... | KUGELMAN LARRY | Director | Grant | A | 21.07 | 5,695 | 119,994 | 20,804 | 15.1 K to 20.8 K (+37.69 %) |